Saudi Journal of Gastroenterology
Home About us Instructions Submission Subscribe Advertise Contact Login    Print this page  Email this page Small font sizeDefault font sizeIncrease font size 
Users Online: 13494 
SPECIAL COMMUNICATION
Year : 2020  |  Volume : 26  |  Issue : 5  |  Page : 233-239

Saudi association for the study of liver diseases and transplantation position statement on liver transplantation during the COVID-19 pandemic


1 Division of Transplant, Department of Surgery, University of Rochester; Division of Gastroenterology, Department of Medicine, University of Rochester, Rochester, New York, United Sates of America
2 Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
3 Department of Medicine, King Fahad Military Medical Complex, Dhahran, Saudi Arabia
4 Department of Medicine, King Saud University, Riyadh, Saudi Arabia
5 Multiorgan Transplant Center, King Fahad Specialist Hospital, Dammam, Saudi Arabia
6 Multiorgan Transplant Center, King Fahad Specialist Hospital, Dammam; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia
7 College of Medicine, Alfaisal University; Liver Transplantation and Organ Transplant Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
8 Gastroenterology Unit, Department of Medicine, King Abdulaziz Medical City, Jeddah, Saudi Arabia

Correspondence Address:
Dr. Bandar Al-Judaibi
University of Rochester, 500 Joseph C. Wilson Blvd., Rochester, NY - 14627
United Sates of America
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/sjg.SJG_131_20

Rights and Permissions

The World Health Organization (WHO), on March 11th 2020, upgraded the status of the novel coronavirus disease (COVID-19) from epidemic to pandemic. Over two million individuals have been infected with SARS-CoV-2, the virus causing COVID-19, and as of April, 14th 2020, there were over 5000 confirmed cases in Saudi Arabia (SA). Many countries, including SA, have imposed major restrictions on travel, and everyday life, and the implications of these necessary changes are being felt in liver transplant (LT) centers in SA. Concerns remain that there is an increased risk for individuals over 65 years of age, with underlying medical conditions, or for those who are immunocompromised. Therefore, the Saudi Association for the Study of Liver Diseases and Transplantation (SASLT) established an urgent task force to launch a statement that can be utilized by LT centers as a guidance in the management of patients with advanced liver disease from the time of LT listing to the post-operative care of transplanted patients.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1864    
    Printed72    
    Emailed0    
    PDF Downloaded123    
    Comments [Add]    

Recommend this journal